Friday, February 28, 2014

Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from...

Background: De-escalating natalizumab (NTZ) to interferon beta 1b (IFN B 1B) is a possible http://t.co/NbjdWwB5Ug

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/NbjdWwB5Ug
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)